US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Masimo Corp

us-stock
To Invest in {{usstockname}}
us-stock
$138 -0.0288(-2.88%) MASI at 04 Dec 2025 04:38 PM Medical Devices
Lowest Today 137.49
Highest Today 149.345
Today’s Open 144.49
Prev. Close 142.19
52 Week High 194.88
52 Week Low 133.70
Day’s Range: Low 137.49 High 149.345
52-Week Range: Low 133.70 High 194.88
1 day return -
1 Week return -3.15
1 month return -7.43
3 month return -3.44
6 month return -15.29
1 year return -19.59
3 year return -3.16
5 year return -47.95
10 year return -

Institutional Holdings

BlackRock Inc 19.34

FMR Inc 15.06

Politan Capital Management LP 8.68

Vanguard Group Inc 8.54

T. Rowe Price Investment Management,Inc. 4.60

Massachusetts Financial Services Company 4.55

Capital Research Global Investors 3.42

MFS Mid Cap Growth Equity 3.08

MFS Mid Cap Growth A 3.00

Vanguard Total Stock Mkt Idx Inv 2.82

State Street Corp 2.74

iShares Core S&P Mid-Cap ETF 2.70

Fidelity Select Health Care 2.63

Fidelity Select Medical Tech and Devcs 2.49

Holocene Advisors, LP 2.29

American Funds SMALLCAP World A 2.23

BlackRock Mid-Cap Growth Equity Instl 2.20

Vanguard Small Cap Index 2.18

Westfield Capital Management Company, L.P. 2.17

Durable Capital Partners LP 2.14

Alyeska Investment Group, L.P. 2.09

BlackRock Global Uncons Eq Z USD Acc 1.95

Geode Capital Management, LLC 1.65

AllianceBernstein L.P. 1.55

Fidelity Advisor Health Care I 1.48

Strategic Advisers Fidelity US TtlStk 1.46

Viking Global Investors LP 1.41

Morgan Stanley - Brokerage Accounts 1.41

T. Rowe Price US Small-Cap Core Equity 1.37

Liontrust Investment Partners LLP 1.30

RTW INVESTMENTS, LLC 1.26

Vanguard Small Cap Growth Index Inv 1.23

T. Rowe Price Small-Cap Stock 1.19

Dimensional Fund Advisors, Inc. 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.89

Goldman Sachs Group Inc 0.87

BlackRock GlbUncons Eq Fd (UK) Z GBPAcc 0.87

T. Rowe Price US Mid-Cap Growth Equity 0.74

T. Rowe Price Mid-Cap Growth 0.73

Fidelity VIP Mid Cap Initial 0.73

Market Status

Strong Buy: 4

Buy: 2

Hold: 3

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 7637.59 M

PB Ratio 9.5511

PE Ratio 0.0

Enterprise Value 8010.32 M

Total Assets 2625.70 M

Volume 1219262

Company Financials

Annual Revenue FY24:2094400000 2094.4M, FY23:2116200000 2116.2M, FY22:2035800000 2035.8M, FY21:1239153000 1239.2M, FY20:1143744000 1143.7M

Annual Profit FY24:1004400000 1004.4M, FY23:1054200000 1054.2M, FY22:1058800000 1058.8M, FY21:808347000 808.3M, FY20:743065000 743.1M

Annual Net worth FY24:-304900000 -304.9M, FY23:88500000 88.5M, FY22:143500000 143.5M, FY21:229647000 229.6M, FY20:240302000 240.3M

Quarterly Revenue Q3/2025:371500000 371.5M, Q2/2025:370900000 370.9M, Q1/2025:372000000 372.0M, Q4/2024:600700000 600.7M, Q3/2024:504600000 504.6M

Quarterly Profit Q3/2025:230600000 230.6M, Q2/2025:233300000 233.3M, Q1/2025:234000000 234.0M, Q4/2024:244700000 244.7M, Q3/2024:263200000 263.2M

Quarterly Net worth Q3/2025:-100400000 -100.4M, Q2/2025:51300000 51.3M, Q1/2025:-170700000 -170.7M, Q4/2024:-349600000 -349.6M, Q3/2024:9800000 9.8M

Fund house & investment objective

Company Information Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Organisation Medical Devices

Employees 3600

Industry Medical Devices

CEO Ms. Catherine M. Szyman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right